Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial Mary CianfroccaSandra LeeJoseph A. Sparano Original Article 05 January 2011 Pages: 827 - 833
Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63 Shu-Er ChowYing-Ling ChangJong-Shyan Wang Original Article 05 January 2011 Pages: 835 - 845
Interactions of bexarotene (LGD1069, Targretin) with the coagulation system Anne HespelNajet Mejdoubi-CharefSaid Charef Original Article 13 January 2011 Pages: 847 - 854
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma Makiko MoriMamoru TsukudaSayaka Iwahana Original Article 13 January 2011 Pages: 855 - 862
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group H. H. YoonP. CatalanoK. M. Murphy Original Article 01 February 2011 Pages: 863 - 870
Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan Xin LiuWei-Jian GuoJin Li Original Article 01 February 2011 Pages: 871 - 878
Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model Hongju WuYan XinShasha Wang Original Article 03 February 2011 Pages: 879 - 887
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib Paul MathewNizar TannirLance Pagliaro Original Article 03 February 2011 Pages: 889 - 896
Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer Bruno José Dumêt FernandesCarolina de Miranda SilvaVera Lucia Lanchote Original Article 03 February 2011 Pages: 897 - 904
A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer Yoon Hee ChoiTae Won KimYoon-Koo Kang Original Article 03 February 2011 Pages: 905 - 912
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models Dong Hoe KooBaek-Yeol RyooYoon-Koo Kang Original Article 03 February 2011 Pages: 913 - 921
SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors Andrea D. BassoMing LiuPaul Kirschmeier Original Article 05 February 2011 Pages: 923 - 933
Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients I. G. HwangJ. S. JangS. J. Lee Original Article 05 February 2011 Pages: 935 - 944
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer G. P. StathopoulosD. AntoniouP. Michalopoulou Original Article Open access 08 February 2011 Pages: 945 - 950
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer Dhaval K. ShahJean VeithJoseph P. Balthasar Original Article 09 February 2011 Pages: 951 - 958
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors Alejandro D. RicartEdward A. AshtonScot C. Remick Original Article 09 February 2011 Pages: 959 - 970
Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors Pin ZhangMingyuan SunBinghe Xu Original Article 09 February 2011 Pages: 971 - 978
Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin Isao KanataniXinjian LinStephen B. Howell Original Article Open access 16 February 2011 Pages: 979 - 990
Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer Hong Jae ChonSun Young RhaHei-Cheul Jeung Original Article Open access 16 February 2011 Pages: 991 - 999
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) A. CantaA. ChiorazziG. Cavaletti Original Article 16 February 2011 Pages: 1001 - 1008
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial R. MurialdoF. BertolottiAlberto Ballestrero Original Article 16 February 2011 Pages: 1009 - 1016
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting Kyu-Hyoung LimTae-Yong KimYung-Jue Bang Original Article 17 February 2011 Pages: 1017 - 1026
Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer Zheng-tao ZhouFu-xiang ZhouXu-shen Peng Original Article 17 February 2011 Pages: 1027 - 1032
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer Ahmed Ashour AhmedJuliet GoldsmithWaldemar Priebe Original Article Open access 22 February 2011 Pages: 1033 - 1044
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Jin Hyun ParkSae-Won HanJae-Gahb Park Original Article 22 February 2011 Pages: 1045 - 1055
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study Jane E. MinturnAudrey E. EvansJohn M. Maris Original Article 22 February 2011 Pages: 1057 - 1065
Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma Gilberto de Lima Lopes JrJennifer S. DickseyAlex Y. Chang Original Article 23 February 2011 Pages: 1067 - 1073
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL John L. ReaganAlan RosmarinAnthony E. Mega Clinical Trial Report 15 July 2011 Pages: 1075 - 1080
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma Zeynep ErogluKevin M. KongJohn P. Fruehauf Clinical Trial Report Open access 19 July 2011 Pages: 1081 - 1087
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation Yosuke TogashiKatsuhiro MasagoMichiaki Mishima Short Communication Open access 17 June 2011 Pages: 1089 - 1092
Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro Johanna WeissWalter Emil Haefeli Short Communication 31 July 2011 Pages: 1093 - 1098
